On this page
Buminate, Flexbumin
Albumin (Human)
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Buminate, Flexbumin
Proper name
Albumin (Human)
Licence type
351(a)
BLA number
101452
Applicant
Takeda Pharmaceuticals U.S.A., Inc.
Center
CBER
Presentations
5
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 10G/50ML | Injection | Intravenous | Bottle | Rx | March 3, 1954 |
| 12.5G/250ML | Injection | Intravenous | Bottle | Rx | March 3, 1954 |
| 12.5G/50ML | Injection | Intravenous | Bottle | Rx | March 3, 1954 |
| 20G/100ML | Injection | Intravenous | Bottle | Rx | March 3, 1954 |
| 25G/100ML | Injection | Intravenous | Bottle | Rx | March 3, 1954 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |